Dissecting Causal Links Between Gut Microbiota, Inflammatory Cytokines, and Parkinson's Disease: A Mendelian

Ma Caiyun1, Wen Hebao1,2, Ye Wenhao1

  • 1Anhui Engineering Research Center for Neural Regeneration Technology and Medical New Materials, Bengbu Medical University, Bengbu, China.

Brain and Behavior
|November 28, 2024
PubMed
Abstract

Insights

This study investigates the causal link between gut microbiota (GM) and Parkinson's disease (PD), exploring the mediating role of inflammatory cytokines (ICs). Findings suggest a connection, with potential cytokine mediation pathways identified.

Area of Science:

  • Neuroscience
  • Microbiology
  • Genetics

Background:

  • The association between gut microbiota (GM) and Parkinson's disease (PD) is known, but causality and the role of inflammatory cytokines (ICs) as mediators are unclear.
  • Investigating these relationships is crucial for understanding PD pathogenesis.

Purpose of the Study:

  • To investigate the causal relationships between GM, ICs, and PD using Mendelian randomization (MR).
  • To examine the potential mediating role of ICs in the GM-PD association.

Main Methods:

  • Utilized large-scale genome-wide association studies (GWAS) summary databases.
  • Performed Mendelian randomization (MR) analyses, primarily using the inverse-variance weighted (IVW) method.
  • Employed MR Egger and weighted median methods for supplementary analysis and two-step MR for mediation analysis.

Main Results:

  • Identified several potential causal relationships between specific GM and PD, and between ICs and PD, though none remained significant after FDR adjustment.
  • Reverse MR analysis indicated causal links between PD and various GM and ICs.
  • Two-step MR suggested that phylum Actinobacteria may negatively impact PD risk, potentially mediated by Fms-related tyrosine kinase 3 ligand levels.

Conclusions:

  • Strengthened the evidence linking gut microbiota to Parkinson's disease risk.
  • Revealed the potential mediating role of inflammatory cytokines in the complex interplay between gut microbiota and PD.